Numerous studies have demonstrated that CD47 is selectively enriched in the CSC population compared to bulk tumor cells in various malignancies, including AML [99], lung [103, 104], bladder [105], hepatic [102], colorectal [100], pancreatic [106], ovarian [109], esophageal [111] and breast cancer [108]. This evidence concerns the gene CD47 and neoplasm.